CamAPS FX is a sophisticated, easy-to-use mobile app to manage glucose levels in people with type 1 diabetes, aged one year and older, using an advanced adaptive hybrid closed-loop approach.
The app has been extensively tested in clinical trials and approved for use including in the UK, the EU, the USA, Canada, Australia, and New Zealand.
CamAPS FX is compatible with Dexcom G6 and the FreeStyle Libre 3 . Please click the links to view compatible smartphones and operating systems.
CamAPS FX available through Google Play is compatible with mylife YpsoPump insulin pump. CamAPS FX available through Amazon Appstore is compatible with DANA Diabecare RS and DANA-i insulin pumps.
CamAPS FX runs on Android smartphones supported by your CGM manufacturer with OS 10 and above. It also runs with FreeStyle Libre 3 on iOS 17 or 18, currently in Sweden and rolling out globally soon.
Please click this link for a list of devices and operating systems compatible with the FreeStyle Libre 3 Sensor and the FreeStyle Libre 3 app.
From June 2025, CamAPS FX will only be supported on sensor-compatible phones running Android operating systems 12 and above. Users of operating systems below OS 10, will no longer be able to update or reinstall CamAPS FX after this date.At present, data from CamAPS FX can be uploaded to mylife Cloud and Glooko.
CamAPS FX is available in English, Czech, Danish, German, Spanish, French, Italian, Dutch, Polish, Finnish, and Swedish.
Publications related to the use of Cambridge control algorithm are available to download here. Key publications were published in The Lancet and The New England Journal of Medicine.